Covid-19 Update Debate
Full Debate: Read Full DebateDepartment: Department of Health and Social Care
Tobias Ellwood
Main Page: Tobias Ellwood (Conservative - Bournemouth East)Department Debates - View all Tobias Ellwood's debates with the Department of Health and Social Care
(3 years, 10 months ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Matt Hancock
We have taken action very rapidly when we have seen rises in cases. The most recent example here in England was, of course, right at the start of this year, when we saw the sharp spike in cases and took very rapid action to close schools after some of them had been open for just one day. We do not take such measures lightly and we understand the impact that they have, but they were absolutely necessary.
Mr Tobias Ellwood (Bournemouth East) (Con)
I congratulate my right hon. Friend and the entire team on doing such a phenomenal job in rolling out the life-saving vaccine right throughout the country. It is not, though, in our interest or indeed our character to become a vaccinated island; we have both the means and the desire to help others who do not have such advanced public health infrastructure systems as ours. We are heavily involved in COVAX, Gavi and the encouraging of global vaccine disbursement, but I invite the Secretary of State to go a step further and work with the Secretary of State for Defence and the Foreign Secretary to allocate overseas funds to create an international vaccination taskforce, utilising RFA Argus, our hospital ship, and other military assets to assist practically with the international roll-out of vaccines to developing countries. The UK set an example by stepping forward during the Ebola crisis; I hope we can do the same again today.
Matt Hancock
I would be happy to talk to the Secretary of State for Defence about that idea, because we are leaning into the global vaccination effort, not just with the funding to COVAX and Gavi that my right hon. Friend mentioned but with practical support—including, of course, the Oxford vaccine itself, which is the most deployable vaccine and the only one currently being used that has been distributed at cost. AstraZeneca took the decision to license the Oxford vaccine around the world at cost rather than making a profit on it and should be commended for that.